Debt-to-equity of RIGEL PHARMACEUTICALS INC from 30 Sep 2023 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's debt by its shareholder equity.
- Summary
-
RIGEL PHARMACEUTICALS INC quarterly Debt-to-equity in x history and change rate from 30 Sep 2023 to 31 Dec 2025.
- RIGEL PHARMACEUTICALS INC Debt-to-equity for the quarter ending 31 Dec 2025 was 0.87x.
Debt-to-equity, Quarterly (x)
Debt-to-equity, YoY Quarterly Change (%)
RIGEL PHARMACEUTICALS INC Quarterly Debt-to-equity (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 0.87x | +9.52x | 31 Dec 2025 | |
| Q3 2025 | 2.56x | +8.44x | 30 Sep 2025 | |
| Q2 2025 | 6.7x | +11.69x | 30 Jun 2025 | |
| Q1 2025 | -27.78x | -22.82x | -460% | 31 Mar 2025 |
| Q4 2024 | -8.66x | -3.46x | -67% | 31 Dec 2024 |
| Q3 2024 | -5.88x | +0.13x | +2.2% | 30 Sep 2024 |
| Q2 2024 | -4.99x | 30 Jun 2024 | ||
| Q1 2024 | -4.96x | 31 Mar 2024 | ||
| Q4 2023 | -5.19x | 31 Dec 2023 | ||
| Q3 2023 | -6.01x | 30 Sep 2023 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.